- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Development of replication-competent adenovirus based vaccine vectors ; volume:9 ; number:2 ; day:13 ; month:9 ; year:2012 ; pages:1 ; date:9.2012
Retrovirology ; 9, Heft 2 (13.9.2012), 1, 9.2012
- Urheber
-
Abbink, P.
- Beteiligte Personen und Organisationen
-
Maxfield, LF
Barouch, DH
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-9-S2-P310
- URN
-
urn:nbn:de:1111-2016080725094
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Abbink, P.
- Maxfield, LF
- Barouch, DH
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prime-boost AIDS Vaccine Strategies Based on Replication-Competent Adenovirus Recombinants
Evaluation of a replication-competent VSV-SIV vaccine candidate
Efficient gene silencing in tumor tissue using replication-competent retroviral vectors
Construction and characterization of replication-deficient and cancer-specific replication-competent feline foamy virus vectors
Establishment of a novel cell line for producing replication-competent adenovirus-free adenoviruses
Properties and use of novel replication-competent vectors based on Semliki Forest virus
Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein
Replication competent viruses for cancer therapy
Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs
OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines
Do humans have replication-competent endogenous retroviruses?
New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission
Prime-boost AIDS Vaccine Strategies Based on Replication-Competent Adenovirus Recombinants
Evaluation of a replication-competent VSV-SIV vaccine candidate
Efficient gene silencing in tumor tissue using replication-competent retroviral vectors
Construction and characterization of replication-deficient and cancer-specific replication-competent feline foamy virus vectors
Establishment of a novel cell line for producing replication-competent adenovirus-free adenoviruses
Properties and use of novel replication-competent vectors based on Semliki Forest virus
Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein
Replication competent viruses for cancer therapy
Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs
OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines
Do humans have replication-competent endogenous retroviruses?
New adenovirus-based vaccine vectors targeting Pfs25 elicit antibodies that inhibit Plasmodium falciparum transmission
Prime-boost AIDS Vaccine Strategies Based on Replication-Competent Adenovirus Recombinants
Evaluation of a replication-competent VSV-SIV vaccine candidate
Efficient gene silencing in tumor tissue using replication-competent retroviral vectors
Construction and characterization of replication-deficient and cancer-specific replication-competent feline foamy virus vectors
Establishment of a novel cell line for producing replication-competent adenovirus-free adenoviruses
Properties and use of novel replication-competent vectors based on Semliki Forest virus
Development of a HIV-1 vaccine using an orally-administered, replication-competent adenovirus serotype 4 vector expressing Env clade C glycoprotein
Replication competent viruses for cancer therapy
Beyond the replication-competent HIV reservoir: transcription and translation-competent reservoirs
OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines
Do humans have replication-competent endogenous retroviruses?